Skip to main content

Agilent Prices $750M in Senior Notes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies said last night that it has priced two series of senior notes offerings with an aggregate principal amount of $750 million.

The first series of $250 million in 2.5 percent notes will mature in July 2013. The second series of $500 million in 5 percent notes will mature in July 2020.

Agilent expects to close the offering on July 20.

The firm will use the proceeds to satisfy, in part, the financing obligation of Agilent Technologies World Trade, the subsidiary that acquired Varian for $1.5 billion in May.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.